Dr. Anthony Carter, DO

NPI: 1386610947
Total Payments
$453,196
2024 Payments
$66,300
Companies
4
Transactions
182
Medicare Patients
1,112
Medicare Billing
$130,360

Payment Breakdown by Category

Consulting$453,163 (100.0%)
Food & Beverage$33.16 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $453,163 179 100.0%
Food and Beverage $33.16 3 0.0%

Top Paying Companies

Company Total Records Latest Year
Takeda Pharmaceuticals U.S.A., Inc. $286,363 113 $0 (2024)
Shire North American Group Inc $166,800 66 $0 (2019)
Janssen Pharmaceuticals, Inc $21.73 2 $0 (2018)
Allergan Inc. $11.43 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $66,300 26 Takeda Pharmaceuticals U.S.A., Inc. ($66,300)
2023 $42,863 17 Takeda Pharmaceuticals U.S.A., Inc. ($42,863)
2022 $61,900 24 Takeda Pharmaceuticals U.S.A., Inc. ($61,900)
2021 $55,800 22 Takeda Pharmaceuticals U.S.A., Inc. ($55,800)
2020 $59,500 24 Takeda Pharmaceuticals U.S.A., Inc. ($59,500)
2019 $58,400 24 Shire North American Group Inc ($58,400)
2018 $52,433 21 Shire North American Group Inc ($52,400)
2017 $56,000 24 Shire North American Group Inc ($56,000)

All Payment Transactions

182 individual payment records from CMS Open Payments — Page 1 of 8

Date Company Product Nature Form Amount Type
12/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,750.00 General
12/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,650.00 General
11/13/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,750.00 General
11/13/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,650.00 General
10/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,750.00 General
10/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,650.00 General
09/11/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,750.00 General
09/11/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,650.00 General
09/04/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $1,000.00 General
08/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,750.00 General
08/09/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,650.00 General
07/12/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,750.00 General
07/12/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,650.00 General
06/10/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,750.00 General
06/10/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,650.00 General
05/27/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $1,000.00 General
05/10/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,650.00 General
05/10/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,650.00 General
04/17/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,650.00 General
04/17/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,650.00 General
03/11/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,650.00 General
03/11/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,650.00 General
02/14/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,650.00 General
02/14/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,650.00 General
01/17/2024 Takeda Pharmaceuticals U.S.A., Inc. Consulting Fee Cash or cash equivalent $2,650.00 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 249 253 $228,711 $28,618
2022 6 268 270 $222,593 $30,194
2021 4 297 301 $270,487 $35,603
2020 4 298 304 $271,047 $35,946
Total Patients
1,112
Total Services
1,128
Medicare Billing
$130,360
Procedure Codes
19

All Medicare Procedures & Services

19 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99285 Emergency department visit with high level of medical decision making Facility 2023 145 147 $159,054 $18,824 11.8%
99284 Emergency department visit with moderate level of medical decision making Facility 2023 47 47 $35,015 $4,246 12.1%
99291 Critical care, first 30-74 minutes Facility 2023 19 19 $26,391 $2,960 11.2%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 27 29 $5,336 $1,708 32.0%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 11 11 $2,915 $880.94 30.2%
99285 Emergency department visit for life threatening or functioning severity Facility 2022 137 139 $150,398 $18,821 12.5%
99284 Emergency department visit for problem of high severity Facility 2022 42 42 $30,835 $3,744 12.1%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 33 33 $10,527 $3,305 31.4%
99291 Critical care, first 30-74 minutes Facility 2022 11 11 $14,549 $1,801 12.4%
99283 Emergency department visit for problem of moderate severity Facility 2022 33 33 $13,464 $1,636 12.1%
99221 Initial hospital inpatient care per day, typically 30 minutes Facility 2022 12 12 $2,820 $886.89 31.5%
99285 Emergency department visit, problem with significant threat to life or function Facility 2021 126 126 $134,241 $18,734 14.0%
99284 Emergency department visit, problem of high severity Facility 2021 107 111 $81,735 $9,629 11.8%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2021 30 30 $40,889 $5,647 13.8%
99283 Emergency department visit, moderately severe problem Facility 2021 34 34 $13,622 $1,593 11.7%
99285 Emergency department visit, problem with significant threat to life or function Facility 2020 152 158 $162,376 $21,977 13.5%
99284 Emergency department visit, problem of high severity Facility 2020 105 105 $72,541 $8,943 12.3%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2020 23 23 $29,704 $4,219 14.2%
99283 Emergency department visit, moderately severe problem Facility 2020 18 18 $6,426 $805.87 12.5%

About Dr. Anthony Carter, DO

Dr. Anthony Carter, DO is a Emergency Medicine healthcare provider based in Cedar Rapids, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386610947.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Carter, DO has received a total of $453,196 in payments from pharmaceutical and medical device companies, with $66,300 received in 2024. These payments were reported across 182 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($453,163).

As a Medicare-enrolled provider, Carter has provided services to 1,112 Medicare beneficiaries, totaling 1,128 services with total Medicare billing of $130,360. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.

Practice Information

  • Specialty Emergency Medicine
  • Location Cedar Rapids, IA
  • Active Since 02/24/2006
  • Last Updated 02/26/2008
  • Taxonomy Code 207P00000X
  • Entity Type Individual
  • NPI Number 1386610947

Products in Payments

  • XARELTO (Drug) $21.73
  • DALVANCE (Drug) $11.43

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Emergency Medicine Doctors in Cedar Rapids